Novartis Oncology delivers innovative therapies that change the way patients live with cancer and blood disorders. These include Gleevec^® (imatinib mesylate) tablets, Afinitor^® (everolimus) tablets, Zometa^® (zoledronic acid), Femara^® (letrozole tablets), Sandostatin LAR^® Depot (octreotide acetate for injectable suspension) and Exjade^® (deferasirox).